Platelets are essential mediators of inflammation and thrombosis. Chronic obstructive
pulmonary disease (COPD) is a heterogeneous multisystem disease, causing significant …

COPD and idiopathic pulmonary fibrosis (IPF) together represent a considerable unmet
medical need, and advances in their treatment lag well behind those of other chronic …

Background: Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary
and systemic inflammatory processes, and exacerbation of COPD represents a critical …

Introduction Chronic obstructive pulmonary disease (COPD) is associated with increased
lung and systemic inflammation. We aimed to identify associations between easy-to-obtain …

Platelets play an important role in the pathophysiology of chronic obstructive pulmonary
disease (COPD) by mediating thrombotic, inflammatory, and immune processes in the lung …

Background Little is known about the concordance of atopy with asthma COPD overlap.
Among individuals with COPD, a better understanding of the phenotypes characterized by …

Background Platelet count is a prognostic indicator in the general population and elderly.
Thrombocytosis during acute exacerbation of COPD (AECOPD) has been associated with …

Introduction: Antiplatelet therapy has been associated with fewer exacerbations and
reduced respiratory symptoms in chronic obstructive pulmonary disease (COPD). Whether …

In recent years, there has been a great deal of interest in the identification and validation of
blood-based biomarkers for clinical use in chronic obstructive pulmonary disease (COPD) …

Rationale: Although platelets are considered key inflammatory mediators in respiratory
diseases, their role in bronchiectasis has not been fully explored. Objectives: We …